-
Excessive Calpain and Offspring Cognition After Surgery
2026-08-24
A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to excessive calpain activity, impaired hippocampal BDNF/TrkB signaling, and cognitive deficits in rat offspring. Pharmacological rescue with MDL 28170 or the TrkB agonist 7,8-DHF partially restored synaptic and behavioral outcomes, identifying calpain-dependent signaling as a mechanistic target for neurodevelopmental research.
-
Mitomycin C: From DNA Damage to Immune Strategy
2026-08-24
Mitomycin C is more than a cytotoxic reagent: its covalent DNA damage and TRAIL-sensitizing activity create a platform for testing how tumor-cell death intersects with immune clearance. This article connects established apoptosis signaling research with the Notch1–YY1–ICAM1 findings in hepatocellular carcinoma while defining the evidence boundaries for translational combination studies.
-
Cas9 mRNA–gRNA Editing of LGMN in Breast Cancer
2026-08-23
The reference study developed a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNAs to disrupt LGMN, a metastasis-associated lysosomal protease gene. Its results connect transient CRISPR component delivery with impaired lysosomal/autophagic degradation and reduced breast cancer cell migration, invasion, and experimental lung metastasis.
-
Liraglutide and the Brain-Kidney AVP Axis
2026-08-22
Greenwood and colleagues connect liraglutide treatment with reduced circulating arginine vasopressin (AVP) in healthy humans and identify time- and sex-dependent synaptic phosphorylation changes in the rat pituitary. Their combined clinical, proteomic, reporter-assay, and renal analyses suggest that altered AVP release and aquaporin 2 regulation may contribute to the diuretic and natriuretic effects of GLP-1 receptor agonists.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-22
Peramangalam et al. identify an enhancer-dependent MYCN program and its downstream effector eIF4G1 as essential components of survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-associated transcriptional disruption to a therapeutically relevant N-MYC/eIF4G1 dependency using transcriptomic, chromatin, genetic, primary-cell, and patient-derived xenograft models.
-
Vidarabine Monohydrate: Antiviral Research Guide
2026-08-21
Vidarabine monohydrate is a purine nucleoside analog used to study inhibition of viral DNA synthesis and DNA replication interference. The C6377 product is supplied at ≥98% purity, is reported as DMSO-soluble but insoluble in water and ethanol, and is intended for research use only.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-20
This 2025 review integrates tumor hypoxia, metabolic reprogramming, nutrient competition, and immune dysfunction into a unified model of immunosuppressive tumor microenvironment formation. Its main practical value is to connect oxygen-regulated metabolism with immune-cell state, while emphasizing that metabolism-based therapies and biomarkers remain highly context dependent.
-
Protease Inhibitor Cocktail: Plant Stability
2026-08-20
This scenario-driven guide explains how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1011, can reduce protein degradation during plant lysate preparation without being confused with a direct cell-viability reagent. It covers compatibility, dilution, controls, interpretation, and practical vendor-selection criteria for Western blotting and related protein assays.
-
FLAG tag Peptide: Workflow for Exosome Studies
2026-08-19
The FLAG tag Peptide (DYKDDDDK) combines selective recombinant protein detection with gentle competitive elution for native-complex workflows. This practical guide shows how to apply it to RAB31-centered exosome studies, compare single and 3X FLAG designs, and troubleshoot recovery, background, and cleavage problems.
-
Ellagic acid for CK2 and senescence assays
2026-08-19
Ellagic acid provides a mechanistic way to interrogate casein kinase 2 signaling, apoptosis, and oxidative-stress phenotypes alongside senescence-focused screens. This workflow combines biochemical target validation, cell-state selectivity testing, and machine-learning-informed assay design without assuming that CK2 inhibition alone proves senolytic activity.
-
(-)-JQ1 in N-MYC/eIF4G1 AML Assays
2026-08-18
(-)-JQ1 is a JQ1 stereoisomer that helps distinguish BET-dependent biology from scaffold, vehicle, and assay artifacts. This article connects rigorous negative-control design with the N-MYC/eIF4G1 survival axis identified in inv(16) AML research.
-
SmD2 Acetylation Rewires HCC Splicing and PARP Response
2026-08-18
A 2024 Nature Communications study identifies acetylation-dependent control of the core spliceosome protein SmD2 as a determinant of DNA-repair gene splicing and PARP-inhibitor response in hepatocellular carcinoma. The work connects p300-mediated SmD2 degradation and HDAC2-mediated stabilization with BRCA1/FANC cassette-exon regulation, supporting HDAC–PARP inhibitor combinations as a preclinical strategy in HCC.
-
DDX23 Restricts SVA Through Caspase Pathways
2026-08-17
A 2025 Journal of Virology study defines a two-sided interaction between the host RNA helicase DDX23 and Senecavirus A (SVA) proteins 3A and 2B. The work links residue-specific viral protein effects to distinct caspase-dependent degradation routes and validates their importance using recombinant viruses, providing a mechanistic framework for studying SVA immune evasion.
-
Ellagic acid in CK2 and senescence assays
2026-08-17
Ellagic acid enables mechanism-first interrogation of casein kinase 2 signaling, apoptosis, oxidative stress, and senescence phenotypes. This guide translates its biochemical selectivity and formulation constraints into practical workflows for target engagement, cancer biology research, and exploratory senolytic assays.
-
Esflurbiprofen: Fast-Onset Antidepressant Mechanism
2026-08-16
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the serotonin transporter–neuronal nitric oxide synthase interaction in the dorsal raphe nucleus. Its combination of mBRET-based screening, mouse stress models, mechanistic neurobiology, and resting-state fMRI provides a translational framework for targeting serotonergic autoreceptor feedback rather than relying on delayed SSRI adaptation.